| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 |
|---|---|---|---|---|---|---|---|---|---|---|
Sales, net | ||||||||||
41,797 | 33,274 | 34,493 | 29,826 | - | - | - | - | - | - | - |
Sales, net | ||||||||||
- | - | - | - | 29,552 | 34,520 | 30,785 | 33,644 | 32,102 | 36,219 | 38,981 |
Cost of sales | ||||||||||
Cost of manufactured product | ||||||||||
- | - | - | - | 16,509 | 19,770 | 18,000 | 19,776 | 18,556 | 20,757 | 22,659 |
Royalty expense to shareholder | ||||||||||
- | - | - | - | 2,477 | 2,728 | 2,474 | 2,691 | 2,643 | 2,940 | 2,806 |
Total cost of sales | ||||||||||
27,659 | 23,052 | 24,522 | 19,484 | 18,987 | 22,498 | 20,475 | 22,468 | 21,199 | 23,698 | 25,465 |
Gross profit | ||||||||||
14,137 | 10,221 | 9,971 | 10,342 | 10,565 | 12,021 | 10,309 | 11,176 | 10,902 | 12,521 | 13,516 |
Operating expenses | ||||||||||
Sales and marketing | ||||||||||
4,217 | 4,404 | 4,658 | 4,025 | 3,837 | 3,967 | 4,414 | 4,220 | 3,439 | 3,674 | 4,372 |
Research and development | ||||||||||
516 | 621 | 740 | 571 | 607 | 616 | 837 | 871 | 815 | 885 | 1,030 |
General and administrative | ||||||||||
6,432 | 6,786 | 8,351 | 8,795 | 9,328 | 9,595 | 10,989 | 10,022 | 10,738 | 14,260 | 18,814 |
Impairment of assets | ||||||||||
- | - | - | 456 | - | - | - | - | - | 365 | 2,594 |
Total operating expenses | ||||||||||
11,166 | 11,811 | 13,750 | 13,849 | 13,773 | 14,179 | 16,241 | 15,115 | 14,992 | 19,185 | 26,811 |
Income from insurance proceeds | ||||||||||
- | 260 | - | - | - | - | - | - | - | - | - |
Income (loss) from operations | ||||||||||
2,971 | -1,329 | -3,778 | -3,507 | -3,207 | -2,157 | -5,931 | -3,938 | -4,089 | -6,663 | -13,295 |
Litigation proceeds | ||||||||||
- | - | - | - | 7,724 | - | - | - | 5,700 | 9,159 | - |
Interest and other income | ||||||||||
351 | 153 | 65 | 26 | 24 | 33 | 38 | 46 | 62 | 32 | 57 |
Interest expense | ||||||||||
166 | 177 | 210 | 213 | 219 | 222 | 230 | 231 | 240 | 302 | 21 |
Income (loss) before income taxes | ||||||||||
3,156 | -1,353 | -3,923 | -3,693 | 4,322 | -2,346 | -6,122 | -4,123 | 1,432 | 2,224 | -13,259 |
Provision (benefit) for income taxes | ||||||||||
7 | -13 | -187 | 1 | 7 | 8 | 90 | 9 | 13 | -176 | -3,837 |
Net income (loss) | ||||||||||
3,148 | -1,339 | -3,736 | -3,694 | 4,314 | -2,354 | -6,213 | -4,132 | 1,418 | 2,400 | -9,422 |
Preferred Stock dividend requirements | ||||||||||
702 | 704 | 704 | 704 | 709 | 915 | 916 | 918 | 964 | 1,370 | 1,370 |
Deemed capital contribution on extinguishment of preferred stock | ||||||||||
- | - | - | - | 2,305 | - | - | - | - | - | - |
Income (loss) applicable to common shareholders | ||||||||||
2,445 | -2,044 | -4,441 | -4,399 | 5,910 | -3,269 | -7,129 | -5,051 | 454 | 1,030 | -10,793 |
Basic earnings (loss) per share | ||||||||||
0.07 | -0.06 | -0.14 | -0.15 | 0.21 | -0.12 | -0.26 | -0.19 | 0.02 | 0.04 | -0.45 |
Diluted earnings (loss) per share | ||||||||||
0.07 | -0.06 | -0.14 | -0.15 | 0.20 | -0.12 | -0.26 | -0.19 | 0.02 | 0.04 | -0.45 |
Weighted average common shares outstanding: | ||||||||||
Basic (in shares) | ||||||||||
32,672 | 32,666 | 31,958 | 29,354 | 27,822 | 27,375 | 26,999 | 26,219 | 24,171 | 23,872 | 23,806 |
Diluted (in shares) | ||||||||||
32,672 | 32,666 | 31,958 | 29,354 | 29,481 | 27,375 | 26,999 | 26,219 | 26,354 | 26,248 | 23,806 |
Costs of manufactured product | ||||||||||
Total cost of sales | ||||||||||
24,209 | 20,108 | 21,658 | 16,957 | - | - | - | - | - | - | - |
Royalty expense to shareholder | ||||||||||
Total cost of sales | ||||||||||
3,449 | 2,944 | 2,864 | 2,527 | - | - | - | - | - | - | - |